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To contribute to devise successful beta-cell differentiation strategies for the cure of Type 1 diabetes we
sought to uncover barriers that restrict endocrine fate acquisition by studying the role of the tran-
scriptional repressor REST in the developing pancreas. Rest expression is prevented in neurons and in
endocrine cells, which is necessary for their normal function. During development, REST represses a
subset of genes in the neuronal differentiation program and Rest is down-regulated as neurons differ-
entiate. Here, we investigate the role of REST in the differentiation of pancreatic endocrine cells, which
are molecularly close to neurons. We show that Rest is widely expressed in pancreas progenitors and that
it is down-regulated in differentiated endocrine cells. Sustained expression of REST in Pdx1þ progenitors
impairs the differentiation of endocrine-committed Neurog3þ progenitors, decreases beta and alpha cell
mass by E18.5, and triggers diabetes in adulthood. Conditional inactivation of Rest in Pdx1þ progenitors
is not sufﬁcient to trigger endocrine differentiation but up-regulates a subset of differentiation genes. Our
results show that the transcriptional repressor REST is active in pancreas progenitors where it gates the
activation of part of the beta cell differentiation program.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
Type 1 diabetes (T1D) is caused by an absolute deﬁciency of
insulin secretion due to autoimmune destruction of insulin-se-
creting beta cells and can be treated by islet cell replacement
therapy. However, the lack of high quality donor cells has
prompted the search for alternative sources of beta cells to try
generating an unlimited supply of beta cells for transplantation.
There are promising ﬁndings demonstrating in vivo transdiffer-
entiation of acinar, alpha or delta cells into beta cells (Chera et al.,
2014; Collombat et al., 2009; Zhou et al., 2008) or differentiation of
human embryonic stem cells (ESC) to islet cells (Kroon et al., 2008;
Pagliuca et al., 2014; Rezania et al., 2014). However, the differ-
entiation of these cells into beta cells is often partial, a problem
which can potentially be solved by better understanding how beta
cells differentiate during pancreas embryogenesis.
During development, endocrine cells originate fromopenhagen, 3B Blegdamsvej,
. Grapin-Botton).progenitors in two differentiation waves. Between E8.5 and E12.5,
pancreas progenitors are multipotent and can give rise to acinar,
ductal and endocrine cells, most of which express glucagon (Kopp
et al., 2011; Pan et al., 2013; Solar et al., 2009). After E13.5, the
progenitors have become polarized, part of their transcriptional
program has changed and they become bi-potent, giving rise to
ductal and endocrine cells, while the acinar compartment be-
comes segregated. Beta cells are essentially born at these stages
and until shortly after birth (Johansson et al., 2007; Kopp et al.,
2011). We know that a transient Neurog3 expression in progenitors
is necessary to direct endocrine differentiation (Gradwohl et al.,
2000; Gu et al., 2002) and that the pro-endocrine commitment
only proceeds when Neurog3 expression levels reach a threshold
(Wang et al., 2008, 2010), triggering direct activation by NEUROG3
of several pro-endocrine transcription factors (Gittes, 2009; Pan
and Wright, 2011).
Cell fate decision is, however, the result of inputs from positive
as well as negative signals. It is therefore essential to take into
account the interplay between the positive drive established by
pro-endocrine genes such as Neurog3 and restrictive signals. One
such antagonistic signal comes from the Notch effector HES1
which constrains endocrine cell formation by negatively
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2000). Another factor that might be considered as an attractive
new player in this repressive function is the RE-1 Silencing Tran-
scription Factor (REST). This zinc ﬁnger transcription factor binds
to a 21 bp motif called Repressor Element-1 (RE-1) and recruits
several chromatin modiﬁers to block the expression of its target
genes (Ooi and Wood, 2007). Given that the ﬁrst identiﬁed REST
targets were associated to terminal function of neurons and be-
cause REST is mainly absent from mature neuronal cells, REST has
originally been considered as a master repressor of neuronal traits
outside of the central nervous system (Chong et al., 1995;
Schoenherr and Anderson, 1995). However, a number of new
ﬁndings have challenged this assertion. First, genome wide ana-
lyses of the REST regulon have revealed the existence of a wider
than originally thought set of RE-1 containing genes, some of them
bearing a non-canonical motif (Otto et al., 2007). Hundreds of new
RE-1-bearing genes have been identiﬁed and shown to be bound
by REST in diverse cell types and contexts (Johnson et al., 2007,
2008; Otto et al., 2007). Importantly, these reports also empha-
sized that several subsets of REST target genes were associated to
non-neuronal functions, showing that REST is not merely a re-
pressor of neuronal traits (Bruce et al., 2004; Johnson et al., 2007,
2008; Mortazavi et al., 2006; Otto et al., 2007; Wu and Xie, 2006).
Second, many studies have linked modulations of REST levels in
non-neuronal cells to non-neuronal pathologies like colon cancer
(Westbrook et al., 2005), cardiac hypertrophy (Kuwahara et al.,
2003) or smooth muscle cell neointimal hyperplasia (Cheong et al.,
2005); for reviews, see Coulson (2005), Majumder (2006), Thiel
et al. (2014).
In the context of pancreatic endocrine cells, in which REST is
excluded (Atouf et al., 1997; Martin et al., 2008), we have pre-
viously shown using RIP-REST transgenic animals, that RE-1-con-
taining genes are essential for glucose homeostasis. Indeed, we
have demonstrated that Rest ectopic expression in pancreatic in-
sulin-producing cells impairs their function and survival by spe-
ciﬁcally down-regulating the expression of important exocytotic
members as well as pro-survival genes (Martin et al., 2008, 2012).
As speciﬁed for a subset of other genes (Pullen et al., 2010;
Quintens et al., 2008), REST is thus “disallowed” in beta cells, as it
is in neurons (Atouf et al., 1997). The observation made by ChIP seq
analysis that REST binds to the chromatin of drivers of islet cell
development (Johnson et al., 2007), together with the fact that
REST clearance in neural progenitors has been evoked as a trigger
for neural differentiation (Ballas et al., 2005), prompted us to as-
sess the role of REST in the developing pancreas.
In the present study, we show that Rest is expressed in pro-
genitors, and is down-regulated in differentiating endocrine cells
during development. We have also generated a transgenic model
of REST gain-of-function in pancreatic progenitors to show that
REST is sufﬁcient to impair the formation of NEUROG3þ pre-
cursors and of differentiated endocrine cells. Finally, using a model
of Rest loss-of-function speciﬁcally directed to pancreatic pro-
genitors we show that REST inhibits the expression of important
factors of endocrine differentiation.2. Materials and methods
2.1. Mouse strains
The mouse lines (Pdx1-tTA, Pdx1-Cre and REST Fl/Fl) were
previously described and are referenced in the result section. The
Swiss Veterinary Ofﬁce and competent Danish authorities ap-
proved all animal experiments. Embryos were collected at in-
dicated times; midday on the day of vaginal plug appearance was
considered E0.5.To generate mice with inducible REST expression (TetO-REST
mice), an XbaI fragment containing the rabbit β-globin intronic
sequence and human Rest cDNA, which served for the generation
of RIP-REST mice (Martin et al., 2008), was sub-cloned into a pUHD
10-3 plasmid downstream of a tetracycline operator (TetO) mini-
mal promoter sequence. The resulting XhoI/KasI fragment was
used for oocytes injection. These mice were used in the absence of
Doxycycline or tetracycline and thus had continuous expression of
the transgene in Pdx1-expressing cells, comprising the epithelial
cells of the pancreas during development as well as beta cells and
a subset of delta cells in the adult.
2.2. Embryonic pancreas preparation
Pancreatic buds were ﬁxed overnight at 4 °C in 4% paraf-
ormaldehyde (PFA). Samples were then washed, and immersed in
phosphate buffer containing 15% sucrose for 24 h for cryo-pre-
servation. Pancreas were ﬁnally incubated in phosphate buffer
containing 7% gelatin and 15% sucrose at 37 °C for 1 h, solidiﬁed at
RT and quickly frozen in methylbutane kept at 65 °C by im-
mersion in dry ice-/EtOH 100%. Blocks were kept at 80 °C until
sectioning.
2.3. Mouse islet isolation and cell lines
The rat insulinoma cell lines INS-1E (Merglen et al., 2004) were
maintained in complete RPMI 1640 medium as previously de-
scribed (Martin et al., 2003). Human carcinoma HeLa cells were
grown in RPMI 1640 supplemented with 10% fetal bovine serum
(FBS), 2 mmol/l L-glutamine, 1 mmol/l sodium pyruvate, 50 U/ml
penicillin and 50 μg/ml streptomycin.
Islets of Langerhans were isolated from adult mice bearing
REST gain-of-function, Rest loss-of-function and control litter-
mates that were anaesthetized by inhalation of 5% halothane
(Arovet) and sacriﬁced. The pancreas was perfused by collagenase
injection into the common bile duct. After excision, the pancreas
was digested at 37 °C. After ﬁltration on a 100 μm cell strainer (BD
Biosciences), the islets were washed in a Hank’s balanced saline
solution (HBSS) and cultured in RPMI 1640 containing 11.1 mmol/l
glucose supplemented with 10% FCS, 10 mmol/l HEPES, 2 mmol/l L-
glutamine, 1 mmol/l sodium pyruvate, 50 μmol/l β-mercap-
toethanol, 50 U/ml penicillin and 50 μg/ml streptomycin.
2.4. Western blotting
Western blots were performed as previously described (Martin
et al., 2012). Speciﬁc protein levels were revealed with polyclonal
rabbit antibodies against human REST (Martin et al., 2003), or with
polyclonal rabbit antibodies against murine REST (07-579, Merck
Millipore). Monoclonal antibodies against α-tubulin (Sigma-Al-
drich) were used to normalize the signals.
2.5. Immunoﬂuorescence and EdU staining
Frozen sections (8 μm) were rehydrated in PBS before 30 min
blocking in phosphate buffer saline (PBS), Bovine serum albumin
(BSA) 1%, Triton 0.2%. Primary antibodies, anti-Glucagon (rabbit;
1:100; Zymed and guinea pig; 1/400; Linco), anti-Insulin (guinea
pig; 1/100; Dako), anti-NEUROG3 (rabbit; 1/500; Beta Cell Biology
Consortium), anti-SOX9 (rabbit; 1/500; Chemicon), anti-PDX1
(goat; 1/2000; Beta Cell Biology Consortium), and anti-Amylase
(rabbit; 1/500; Calbiochem) were incubated overnight at 4 °C.
Secondary antibodies were incubated 1 h at room temperature.
Alexa Fluor secondary antibodies (all from Molecular Probes-In-
vitrogen) were used for multicolor detection. Cell proliferation was
assessed using the EdU Click-iT kit, according to the
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intraperitoneally in pregnant mothers 2 h before dissection. Nuclei
were stained with DAPI (50 ng/ml; Sigma). The sections were
mounted in 50% PBS:50% glycerol and viewed under a Leica
DM5500 or a Zeiss LSM700 confocal microscope.
2.6. In situ hybridization and co-immunohistochemistry
Tissues were cryo-sectionned and post-ﬁxed 10 min with 4%
PFA. Slides were washed twice in RNase free PBS, incubated
30 min in 0.3% H2O2 in PBS to inhibit endogenous peroxidase, and
treated with 0.2 N HcL for 15 min before incubation 10 min with
2 mg/ml proteinase K in PBS at 37 °C. The reaction was stopped
with 5 min incubation in fresh 0.2% glycine in PBS. Slides were
washed twice in PBS, post-ﬁxed 10 min in 4% PFA, and washed
twice in PBS. Slides were then treated twice with freshly prepared
acetic anhydride in triethanolamine at pH8, and ﬁnally washed
twice in PBS and twice in 5X SSC before pre-hybridization. A so-
lution of hybridization, containing 5X saline sodium citrate (SSC)
pH4.5, 50% deionized formamide, blocking reagent (Roche) and
yeast total RNA was added onto slides that were placed at 68 °C in
a humidiﬁed box during 1 h. The buffer was replaced with hy-
bridization buffer containing 1 mg/ml of denatured sense or anti-
sense full length digoxigenin (DIG)-labeled Rest RNA probe, and
the slides, protected with a plastic coverslip, were placed for more
than 24 h at 68 °C for probe hybridization. Slides were then wa-
shed once with 2XSSC pH4.5, three times with 2XSSC pH4.5, 50%
formamide at 60 °C, and ﬁnally once in Tris-buffered saline (TBS)
tween 0.1% (TBST). For probe detection, slides were blocked
30 min with 0.5% blocking reagent in TBST before incubation
overnight at 4 °C with anti-DIG-peroxydase antibodies diluted 1/
5000 in TBST. For tyramide signal ampliﬁcation, a biotinylated
tyramide (Perkin-Elmer) was used diluted 1/500 in TBST for
20 min, and after washing, the complex was recognized by adding
streptavidin-AlexaFluor 594 (Life Technologies) diluted 1/500 in
TBST for 30 min.
To perform immunological detection on the same slides, pri-
mary antibodies diluted in PBS were added onto slides over night
at 4 °C, and after washing, replaced by diluted secondary anti-
bodies conjugated to appropriate ﬂuorophore for 1 h before
washing, DAPI staining and mounting.
2.7. Quantitative real-time PCR
Tissues were dissected in PBS, frozen and kept at 80 °C.
Samples were then thawed and mechanically disrupted on ice.
Total RNA was extracted using the RNeasy Protect Minikit (Qia-
gen). Reverse transcription of cDNA was carried out using the
ImPromII Reverse transcription kit (Promega). For each tissue
analyzed, 1 μg of total RNA was used. The qPCR was carried out
using the Fast SYBR Green master mix (Applied Biosystems) and
the Viia7 real time PCR system from Applied Biosystems. A list of
primer pairs is provided in Supplemental Table 1.
2.8. Plasma glucose levels
Blood samples were obtained from the tail vein of mice to
measure glucose levels using a freestyle pen (Abbott, USA).
2.9. Single-cell gene expression analysis
Single cell qPCR was performed as previously described
(Greggio et al., 2013). Ninety ﬁve single cells were isolated from
E12.5 control (36 cells from 2 pancreata) and REST Fl/Fl-Cre (59
cells from 2 pancreata) embryos, and gene-speciﬁc cDNA samples
were prepared and pre-ampliﬁed using 48 gene primers(Supplemental Table 2). qPCR was performed using 48.48 Dynamic
Array chips (Fluidigm).
Gene expression data were prepared for analysis using Flui-
digm real-time PCR analysis software (v. 4.1.3) with linear deri-
vative baseline correction, a quality correction set to 0.65, and a
melting curve analysis with speciﬁc temperature range of in-
dividual gene amplicons as well as settings of peak sensitivity to
7 and peak ratio threshold to 0.7. Limit of detection for analysis
was set to Ct value 24, and samples (cells) with low house-keeping
gene expression (Actin and Ubc) and poor overall gene expression
were eliminated using automatic outlier identiﬁcation by principle
component analysis (PCA). As a result, 34 primer sets passed the
quality controls of adequate melting curves and limit of detection,
and 49 cells were selected for statistical analyzes. All statistical
analyzes (Outlier identiﬁcation, ANOVA, hierarchical clustering
(HC) analysis, and PCA) and generation of plots (HC, PCA, and
Violin plots) were performed by autoAnalysis function, using
SINGuLAR Analysis Toolset (Fluidigm; v. 3.5.2) in R (The R Foun-
dation for Statistical Computing).
2.10. Genomic PCR
DNA from pancreas and Langerhans islets of adult control and
mutant animals was isolated using the PureLink Genomic DNA kit
(Life Technologies) according to the manufacturer’s instructions.
20 ng of each sample was used to perform a 28 cycles PCR pro-
gram, using primers speciﬁed in Supplemental Table 3 and an-
nealing temperature set to 63 °C. The efﬁciency of Cre-mediated
recombination of the ﬂoxed REST allele was evaluated in pancreas
and islets of Langerhans from adult REST Fl/þ-Cre and REST Fl/Fl-
Cre animals, as speciﬁed in the legend of Supplemental Fig. 4B.
2.11. Quantiﬁcation and statistical analysis
For quantiﬁcation, the entire pancreas was serially sectioned.
The relative area occupied by cells per pancreas was obtained by
counting immunopositive cells on every 4th (E12.5), 6th (E14.5) or
8th (E18.5) section, normalized to the total epithelium area.
NEUROG3 positive cells (matching a DAPIþ nucleus) were coun-
ted manually. For Insulin, Glucagon, PDX1, SOX9, and DAPI, the
positive pixels (surface of section) were quantiﬁed using ImageJ
software. All values are shown as mean7SD with n numbers and
internal replicates indicated in the ﬁgure captions; p values were
calculated using the nonparametric unpaired Mann–Whitney test
unless otherwise indicated; po0.05 was considered signiﬁcant.3. Results
3.1. Rest is expressed in pancreas progenitors but not in endocrine
cells
To understand the role of REST during pancreas development,
we investigated the spatial and temporal expression patterns of
Rest transcripts. We ﬁrst performed qPCR analysis for Rest mRNA
using pancreatic buds at E11.5, 12.5, 13.5 and 14.5 (Fig. 1A). The
relative levels of Rest mRNA decreased with time, suggesting that
REST levels or the proportion of cells expressing this transcription
factor decreases along the differentiation of pancreas. Accordingly,
the decreasing abundance of REST protein in developing pancreas
was also evidenced by western blot experiments (Fig. 1B). As
compared with extracts from native INS-1E cells lacking REST or
INS-1E cells transduced with pcDNA encoding murine REST pro-
tein, quantiﬁcation from extracts of WT pancreatic buds at E12.5,
E14.5 and E18.5 revealed a decreasing level of REST during de-
velopment and undetectable repressor in isolated islets (Fig. 1B).
Fig. 1. Broad Rest expression in early pancreatic epithelium. (A) qPCR analysis shows declining levels of murine Rest transcripts in WT E11.5, 12.5, 13.5 and 14.5 pancreatic
buds. Results are mean7SD. Difference between groups were determined using non parametric one-way ANOVA test. *po0.05; **po0.01; ***po0.001. (B) Left: western
blot experiment showing REST production in developing WT pancreas at E12.5, E14.5, and E18.5. Compared with total extracts from wild type INS-1E cells (WT) or INS-1E
cells transduced with pcDNA encoding murine Rest (REST), REST antibody revealed a speciﬁc band around 200 kDa in total extracts from wild type E12.5, E14.5, and E18.5
pancreatic buds, while this band was absent in islets of Langerhans. Tubulin immunodetection was added as internal control. Right, the quantiﬁcation of REST signal
normalized to tubulin revealed that the levels of REST decreased during pancreas development. (C) Fluorescent in situ hybridization (ISH) for Rest transcript (red) was
performed with sense (S) (upper panel) or antisense (AS) probe (middle and lower panels) on E14.5 WT pancreas. The inset shows cytoplasmic signal for Rest transcripts
(lower panel). Co-immunostaining performed for Glucagon speciﬁes a region devoid of Rest transcripts (green, upper and middle panel and lower panel, left picture) (red,
lower panel, right picture) and staining for SOX9 delineates the domain of bipotent progenitors (green, lower panel, right picture). Blue staining is the DAPI labeling of nuclei.
Scale bars, 50 μm.
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and obtained a speciﬁc signal with the antisense probe at E14.5
(Fig. 1C, middle panel). Co-immunostaining on the same section
for glucagon (Fig. 1C, middle panel and Supplemental Fig. 1) or
insulin (data not shown), together with Rest in situ hybridization,
clearly demonstrated that Rest is excluded from differentiated
endocrine cells. Although antibodies marking progenitors did not
function after in situ hybridization, parallel staining for Rest tran-
scripts and SOX9 protein on two consecutives sections led to the
conclusion that Rest and SOX9 expression are overlapping, sug-
gesting that Rest is expressed in the progenitor cells of the de-
veloping pancreas (Fig. 1C, lower panel). Rest was widely dis-
tributed in the pancreas, including at the periphery, suggestive of
expression in exocrine cells, in agreement with previously re-
ported expression in exocrine cell lines (Atouf et al., 1997). Since
antibodies against NEUROG3 did not function after in situ hy-
bridization and NEUROG3þ cells are scattered throughout theFig. 2. Transgenic mice with conditional Rest transgene expression using a Tet-off sys
construct used to generate the transgenic mice for tetracycline-controlled REST activatio
REST cDNA (Martin et al., 2008) was subcloned into XbaI sites of pUHD10-3. The Xho
activation of human REST transgene in bigenic Pdx1-tTA/TetO-REST animals. Islets were i
that have been treated with Doxycycline (Dox) in utero and during life. Islets were left in
activation. The Tet-off system allows for REST transgene activation without Dox. The
transgenic mice. Results are mean7SD. (C) Western blot analysis shows speciﬁc product
to control TetO-REST animals. Islets were isolated from adult bigenic Pdx1-tTA/TetO-RES
in culture without Dox for REST transgene induction. Nuclear extracts from INS
(D) Immunolabelling for REST (green) and PDX1 (red) shows the pattern of expression
performed on E12.5 and E14.5 pancreas from bigenic Pdx1-tTA/TetO-REST mice grown w
demonstrating the mosaic expression of human REST, as compared with the driver, PDXpancreatic epithelium, it was impossible to draw clear conclusions
from staining on adjacent sections. However, several lines of evi-
dence suggest that Rest is repressed in NEUROG3þ endocrine
progenitors. First, Rest transcript is decreased 5.8 times in Neu-
rog3-YFPþ cells as compared to YFP- cells (http://www.betacell.
org/resources/data/studies/view/study_id/3100 and ArrayExpress
E-CBIL-48) (Soyer et al., 2010). Second, our transcriptome analysis
after NEUROG3 in vivo gain-of-function at E11.25 (Johansson et al.,
2007) shows a 1.9 fold decrease of Rest in the pancreatic bud after
Neurog3 overexpression (http://www.betacell.org/resources/data/
studies/view/study_id/3733) (Cortijo et al., 2012). Altogether, these
observations suggest that Rest is widely expressed in the early
developing pancreas in multipotent pancreatic progenitors before
E12.5 and in bipotent progenitors expressing Sox9 at later devel-
opmental stages, and that Rest is down-regulated in differentiated
endocrine cells.tem, driven by the endogenous Pdx1 promoter. (A) schematic organization of the
n (TetO-REST mice). The XbaI fragment encompassing β-globin intron and human
I/KasI fragment was used for oocytes injection. (B) qPCR analysis shows speciﬁc
solated from adult Pdx1-tTA/TetO-REST (n¼3) from different lines of founders mice
culture 24 h with (þ) or without () Dox and tested for Dox-dependent transgene
levels of transgene activation were compared to the levels achieved in RIP-REST
ion of human REST in islets isolated from bigenic Pdx1-tTA/TetO-REST as compared
T mice that have been treated with Dox in utero and during life. Islets were left 24 h
1-E or HeLa cells were used as negative and positive controls, respectively.
of the human REST transgene in comparison with its driver, Pdx1. Staining were
ithout Dox. Insets show in higher magniﬁcation partial co-localization at both stage,
1. Scale bars, 50 μm.
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pendent REST expression
To challenge the hypothesis that REST may inﬂuence endocrine
pancreatic development, we ﬁrst adopted a gain-of-function
strategy to express Rest in all the cells of the epithelium, from early
stages on, and to assess whether this mis-expression is sufﬁcient
to impair endocrine differentiation. We sub-cloned a fragment
containing the human REST cDNA, which served for the generation
of RIP-REST mice (Martin et al., 2008), downstream of a tetra-
cycline operator (TetO) minimal promoter sequence (Fig. 2A). TheFig. 3. Quantiﬁcation of endocrine progenitor and differentiated cell populations in bige
quantiﬁed in E14.5 pancreas from Pdx1-tTA control (n¼6) and bigenic Pdx1-tTA/TetO-R
overexpressing pancreas. *po0.05 versus values of control littermates. (B) SOX9þ/DAP
Pdx1-tTA/TetO-REST (n¼8) mice grown without Dox. (C) Insulinþ/DAPI area was quantiﬁ
TetO-REST (n¼5) mice grown without Dox. Insulinþ cell number is reduced in REST-ov
Glucagonþ/DAPI area was quantiﬁed in E14.5 and E18.5 pancreas from Pdx1-tTA control
cell number is reduced in REST-overexpressing pancreas at E18.5. **po0.01 versus valu
from Pdx1-tTA control (n¼5) and bigenic Pdx1-tTA/TetO-REST (n¼5) mice grown witho
staining in E18.5 pancreas from Pdx1-tTA control and bigenic Pdx1-tTA/TetO-REST. Arr
Right, quantiﬁcation of the % of Insulinþ/EdUþ in E18.5 pancreas from Pdx1-tTA controconstruct was then used to generate mice expressing tetracycline-
inducible Rest transgene (TetO-REST) by pronuclear injection in
oocytes. The four founder lines that we obtained were bred se-
parately with transgenic mice driving the expression of a tetra-
cycline-repressible transactivator (tTA) under the control of the
endogenous Pdx1 transcriptional regulatory sequence (Pdx1-tTA)
(Hale et al., 2005; Holland et al., 2002). Bigenic Pdx1-tTA/TetO-
REST mice bear a Tet-off regulatory cassette allowing Rest ex-
pression in the absence of Doxycycline (Dox) treatment.
To check for proper transgene activation with the Tet-off sys-
tem in vivo, we quantiﬁed the level of human Rest expression bynic Pdx1-tTA/TetO-REST. (A) NEUROG3þ cell number normalized to DAPI area was
EST (n¼8) mice grown without Dox. NEUROG3þ cell number is reduced in REST-
I area was quantiﬁed in E14.5 pancreas from Pdx1-tTA control (n¼6) and bigenic
ed in E14.5 and E18.5 pancreas from Pdx1-tTA control (n¼5) and bigenic Pdx1-tTA/
erexpressing pancreas at E18.5. **po0.01 versus values of control littermates. (D)
(n¼5) and bigenic Pdx1-tTA/TetO-REST (n¼5) mice grown without Dox. Glucagonþ
es of control littermates. (E) Amylaseþ/DAPI area was quantiﬁed in E18.5 pancreas
ut Dox. (F) Left, representative image of EdU (red), REST (green) and Insulin (white)
ows indicate proliferative Insulinþ/EdUþ double positive cells. Scale bars, 25 μm.
l and bigenic Pdx1-tTA/TetO-REST.
D. Martin et al. / Developmental Biology 405 (2015) 316–327322qPCR, using islets isolated from adult bigenic Pdx1-tTA/TetO-REST.
To avoid REST induction in utero and potential associated defects
in beta cell formation, the mother and the pups were fed with
Dox-containing diet until sacriﬁce for islet isolation. Then, the is-
lets from each animal were split into two groups and cultured forFig. 4. Pdx1-tTA/TetO-REST adult mice are diabetic. (A) Representative immunostaining o
(left panel) or Glucagon (red), REST (green) and insulin (white) (right panel). Left panel sh
REST. Right panel shows Insulinþ/RESTþ double positive cells, while none of the glucago
adult animals show hyperglycemia in bigenic Pdx1-tTA/TetO-REST (n¼6), as compared
Fig. 5. Rest knock-out in multipotent progenitors does not alter pancreas differentiation
controls (REST Fl/Fl; n¼5) and Rest KO (REST Fl/Fl-Cre; n¼5). (A) NEUROG3þ cell num
SOX9þ cell number. (C) SOX9þ cell number. (D and G) NEUROG3þ cell number norma
SOX9þ cell number normalized to DAPI area. There was no difference in cell population24 h with or without Dox. qPCR revealed the absence of Rest in the
islets from bigenic mice cultured with Dox (Fig. 2B), thereby at-
testing for the absence of leakiness of the Tet-off system. Western
blot analysis performed with islets of bigenic and control mice
grown with Dox and cultured for 24 h without Dox revealed thef pancreas from adult bigenic Pdx1-tTA/TetO-REST for PDX1 (red) and REST (green)
ows partial overlap of REST and PDX1 stainings, indicative of a mosaic expression of
nþ cells are labeled for REST. Scale bars, 25 μm. (B) Blood glucose measurements in
to Pdx1-tTA animals (n¼6). ***po0.001 versus values of control littermates.
. (A–H) Cell quantiﬁcation in E10.5 (A–C), E12.5 (D–F) or E14.5 (G, H) pancreas from
ber normalized to SOX9þ cell number. (B) Glucagonþ cell number normalized to
lized to DAPI area. (E and H) Glucagonþ cell number normalized to DAPI area. (F)
s at each stage.
D. Martin et al. / Developmental Biology 405 (2015) 316–327 323presence of REST protein in islets of bigenic animals, as compared
to negative (INS1-E extract) and positive (HeLa extract) controls
(Fig. 2C). The observation of speciﬁc signals in bigenic Pdx1-tTA/
TetO-REST demonstrated that the Rest transgene is expressed in an
inducible manner, in vivo, and leads to the production of REST
protein at the expected size. The line 1666 with highest expression
levels was selected to pursue the experiments.
3.3. Forced expression of REST in PDX1þ progenitor cells impairs the
formation of NEUROG3þ endocrine-committed precursors and sub-
sequent differentiation of endocrine cells
Since Pdx1 gene dosage is important for pancreas formation
and islet architecture (Fujitani et al., 2006) and that Pdx1-tTA mice
are similar to a Pdx1þ / genotype, we used these as controls ra-
ther than the TetO-REST mice. REST was widely detected in the
epithelium of the pancreas at E12.5 and E14.5 (Fig. 2D), although
the antibody has a low afﬁnity and does not detect endogenous
levels (data not shown). The transgene was expressed at higher
levels in PDX1-high cells (Fig. 2D and Supplemental Fig. 2). Despite
this heterogeneity, we observed a signiﬁcant reduction by 20% in
the number of NEUROG3þ endocrine progenitors in E14.5 pan-
creas of Pdx1-tTA/TetO-REST as compared to the Pdx1-tTA control
mice (Fig. 3A), while there was no detectable alteration in the area
of SOX9þ pancreas progenitors (Fig. 3B). Moreover, we observed
20% and 30% decrease in beta- and alpha-cell area, respectively, at
E18.5, whereas there was no difference in beta- and alpha-cell area
at E14.5 (Fig. 3C and D). We did not detect any change in the
exocrine compartment at E18.5 (Fig. 3E). To further distinguish
whether the decrease in beta cell formation arises from a defect in
differentiation or proliferation, we measured EdU incorporation in
insulinþ cells of E18.5 pancreas from control and bigenic embryos
(Fig. 3F). No difference was observed in beta cell proliferation at
this stage. Altogether, our observations strongly suggest that
overexpression of REST in progenitor cells of the developing
pancreas from E8.5 (beginning of Pdx1 expression) is sufﬁcient to
impair the differentiation of endocrine cells observed at late
stages.
3.4. Pdx1-tTA/TetO-REST adult mice are diabetic
Our previous study has shown that ectopic expression of REST
in mature beta cells under the control of the insulin promoter
(RIP-REST mice) impairs both beta cell secretory function as well
as survival (Martin et al., 2008). By analyzing a new RIP-REST
founder line, we further showed that higher levels of REST trans-
gene expression drastically compromised beta cell survival, lead-
ing to diabetes (Martin et al., 2012). Here, we report the same
impairment in glucose homeostasis with another transgenic sys-
tem driving REST expression in adult mature beta cells (under the
control of Pdx1 regulatory region) (Fig. 4A). Indeed, we observed
hyperglycemia in adult bigenic Pdx1-tTA/TetO-REST animals
(Fig. 4B). This is likely to be due to REST interfering with beta-cell
function, since a 20% reduction in beta-cell mass would not be
expected to have such strong physiological outcomes.
3.5. REST blocks a subset of the endocrine differentiation program
After showing that REST overexpression is sufﬁcient to impair
endocrine differentiation, we assessed whether REST loss-of-
function in pancreatic progenitors promotes endocrine differ-
entiation. To address this question, we speciﬁcally deleted the ﬁrst
coding exon of REST in epithelial pancreatic progenitors by
crossing REST Fl/Fl mice (Mao et al., 2011) with mice expressing
Cre recombinase under the control of the Pdx1 promoter (Pdx1-
Cre) (Hingorani et al., 2003). Rest mRNA was decreased by 50% inREST Fl/Fl-Cre pancreata at E12.5, arguing for important but in-
complete inactivation at this stage (Fig. 6A). Genomic PCR in the
adult pancreas also conﬁrmed efﬁcient but incomplete inactiva-
tion (Supplemental Fig. 4).
If REST imposes a brake on endocrine differentiation, its in-
activation from E8.5 on, might result in ectopic or accelerated
pancreatic endocrine differentiation. However, no change in the
proportion of NEUROG3þ cell number was detected in REST Fl/Fl;
Pdx1-Cre embryos (abbreviated REST Fl/Fl-Cre) as compared to
controls (REST Fl/Fl), at E10.5 (Fig. 5A), E12.5 (Fig. 5D) and E14.5
(Fig. 5G). Neurog3 mRNA levels were also unchanged at E12.5
(Fig. 6A). The same observation was made for Glucagonþ cells
(Fig. 5B, E and H), and we detected no impairment in the fraction
of SOX9þ progenitors at E10.5 or E12.5 (Fig. 5C and F). Since in the
nervous system REST represses only part of the neuronal differ-
entiation program (Mao et al., 2011), we investigated whether
endocrine differentiation markers were perturbed after REST
inactivation.
Using ChIPSeq analysis in a T cell line, the study of Johnson
et al., has identiﬁed RE-1 motifs in the chromatin of genes coding
for known crucial transcription factors acting during pancreas
development, although in the lowest range of intensity, indicative
of a weak binding site (Johnson et al., 2007). We investigated the
expression of these putative targets of pancreatic relevance based
on two databases (Bruce et al., 2004; Johnson et al., 2007). We
provide their RE-1 motifs as Supplemental Fig. 3. We also added
some key functional genes of endocrine function and tested by
qPCR in E12.5 pancreata to investigate whether Rest deletion un-
locks their expression. Several important genes involved in en-
docrine cell differentiation, including several genes with RE-1
motifs were increased in REST Fl/Fl-Cre pancreata including Celsr3,
Onecut2, Myt1, Pcsk1 and 2, Chgb, Syt4, Gjd2, Ptprn and Cdk5r2
(Fig. 6A and B). The most striking activation of expression that we
observed among RE-1-containing genes in E12.5 Rest mutants was
nevertheless that of Celsr3 (Fig. 6B), a key component of the planar
cell polarity pathway (PCP) expressed in progenitors and enriched
as they differentiate (Cortijo et al., 2012). This did not correspond
to a general activation of PCP components since expression of
Celsr1 and Vangl2 were not modiﬁed in Rest mutant animals
(Fig. 6B). Some endocrine genes bearing a previously reported RE-
1 motif did not increase, as for example Neurog3, Mfng, Neurod1,
Arx, Pax4, Sst or Chga. Progenitor genes were not modiﬁed (Hes-1,
Sox9, Pdx1, Onecut1, Dner), even those with previously reported
RE-1 motifs (Hes-1, Onecut1, Dner).
Because the inactivation of REST was partial, we resorted to
single-cell PCR to assess the effect of Rest inactivation on in-
dividual cells. The transcripts tested above on whole buds, as well
as additional known REST targets and differentiation genes were
assessed. We found that 60% of the knock-out cells (cluster 2) were
detected as different from control cells by non-supervised clus-
tering and principal component analysis (Fig. 6C). Because the
sensitivity of our initial Fluidigm assays was not sufﬁcient to
measure Rest transcripts, we performed subsequent nested qPCR
on the same samples and found that this population had de-
creased Rest expression (Fig. 6E). These inactivated cells exhibit an
up-regulation of several REST target genes (Chgb, Mapk8ip1, Hnf4a,
Chga, Mafb, Celsr3, Onecut2, Pcsk1, Gjd2, Ptprn, Mfng, Neurod1,
Onecut1 and Pcsk2) shown in violin plot (Fig. 6D). In addition,
endocrine markers such as glucagon, Chgb, Chga, Mafb, and others
were up-regulated together with progenitor markers Sox9, Pdx1,
Cpa1, Ptf1a and Nkx6.1 suggesting that REST inactivation leads to a
confused cell state between a progenitor and an endocrine cell.
Among the other 40% cells that were more similar to control cells,
a partial response was seen in 10 of 13 cells (cluster 1), which also
exhibit a more moderate increase of glucagon, Sox9 and Cpa1.
These cells may be recently or heterozygously recombined. Rest
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hibited heterogeneous expression levels of Rest which may be due
to stochasticity of detection at low expression levels (Fig. 6E). From
our observations, we conclude that even though REST down-reg-
ulation is not able to promote precocious or increased differ-
entiation of endocrine cells at E12.5 or E14.5, it normally acts in
progenitors to block the expression of several important endocrine
differentiation genes.4. Discussion
In this study, we identiﬁed a novel transcription factor in the
gene regulatory network that controls endocrine cell fate alloca-
tion. As Rest expression was evidenced in neuronal progenitors but
not in mature neurons, it was speculated that Rest extinction
might play a role in neuronal differentiation (Chong et al., 1995;
Schoenherr and Anderson, 1995). Ballas et al. were the ﬁrst to
characterize and describe in vitro the gradual clearance of REST
from the chromatin of crucial genes as a trigger for neuronal dif-
ferentiation to proceed (Ballas et al., 2005). Analysis of inducible
knock-out mice for Rest in early progenitors of the developing
brain, under the dependence of the Sox1 promoter, supported the
conclusion that REST is not required for neurogenesis although
inactivation outside of the brain leads to de-repression of REST
targets (Aoki et al., 2012). In contrast, inducible deletion of Rest in
adult neural stem cells under the dependence of the Nestin pro-
moter triggered a transient increase in neurogenesis and depletion
of the hippocampal stem cell pool, indicating a role for REST in
maintaining this pool in a quiescent state by restraining the neu-
rogenic program (Gao et al., 2011). Another study, in which Rest
was deleted in retinal ganglion progenitor cells under the control
of the Six3 promoter, reported that REST controls neurogenesis in
the developing retina. Rest deletion led to an increased number of
retinal ganglion cells, via the upregulation of crucial retinal
ganglion genes, and this occurred independently of the pro-neural
gene Atoh7, which is considered as a master promoter of retinal
neurogenesis (Mao et al., 2011).
Taking into account that pancreatic beta cells share many si-
milarities with neurons, including the fact that REST is also dis-
allowed in these endocrine cells (Atouf et al., 1997; Martin et al.,
2008, 2012; Thiel and Schuit, 2008), we initiated this study to
evaluate the role of REST in endocrine differentiation. We report
that REST is expressed in pancreas progenitors and that its ex-
pression decreases in endocrine progenitors and endocrine cells.
This is in agreement with recent ﬁndings showing that the Rest
gene acquires a Polycomb-mediated H3K27me3 repressive mark
after the pancreatic precursor stage which coincides with the ac-
tivation of a core beta-cell de-repression program (van Arensber-
gen et al., 2010).
To gain further insights into the role that REST may play in
pancreas development, we adopted a gain-of-function strategy,
and forced the expression of Rest in pancreas progenitors to assessFig. 6. Rest knock-out in multipotent progenitors relieves expression of key regulatory el
and Rest KO (REST Fl/Fl-Cre; n¼5) embryos shows a decrease of 50% in the relative ex
including Onecut2, Pcsk1, Myt1, Pcsk2, Chgb, Syt4, Gjd2, Ptprn, and Cdk5r2. Results are m
buds from controls (n¼5) and Rest KO (n¼5) embryos shows a drastic increase in the l
Results are mean7SD. ***po0.001. (C) Left, heatmap of unsupervised hierarchical clus
buds of control or Rest KO embryos. Each column represents a single cell from either
(control, REST Fl/Fl-Cre_Cluster 1 and 2), and rows represent clustering of the 34 genes an
cells, as they express higher levels of endocrine and REST target genes. Right, PCA plot sh
Fl-Cre_Cluster 2 cells differs from both control cells. (D) Violin plot of gene expression ran
higher levels of endocrine genes (including Glucagon, Nkx6.1, PP, and Nkx2.2), as well a
Pcsk1, Gjd2, Ptprn, Mfng, Neurod1, Onecut1 and Pcsk2). E. qPCR analysis of RestmRNA from
both REST Fl/Fl-Cre_Cluster 1 and 2 cells do not express Rest. Differences between group
***po0.001; ns, not signiﬁcant.whether REST clearance is a required event for the pancreas to
differentiate. This led to a decrease in the number of endocrine-
committed progenitors by E14.5 and ultimately reduced the
numbers of glucagonþ and insulinþ cells in E18.5 pancreas.
Eventually, adult mice developed diabetes, an observation that we
already made in RIP-REST mice overexpressing REST speciﬁcally in
beta cells (Martin et al., 2012). Diabetes in Pdx1-tTA/TetO-REST
mice is most likely caused by an impaired function, rather than
being caused by the moderate reduction in insulin-producing cells.
A previous report based on REST gain-of-function experiment via
electroporation in rat neocortical neurons documented a delayed
differentiation and a blocked migration of progenitors upon sus-
tained REST expression (Mandel et al., 2011). Sequence variations
in the RE-1 binding motif establish a hierarchy of binding afﬁnity
for REST to its target genes, indicating that genes bearing a weakly
conserved RE-1 motif have a suboptimal binding afﬁnity for REST
(Bruce et al., 2009). We previously noticed a positive correlation
between Rest levels of expression and the severity of the pheno-
type obtained in our RIP-REST animals (Martin et al., 2012).
Reaching higher levels of REST expression in pancreatic progeni-
tors of our transgenic mice may have caused a stronger phenotype.
We then used the conditional Rest knock-out line generated to
study retinal ganglion cell genesis (Mao et al., 2011) to investigate
the requirement for REST in pancreas differentiation. If REST gates
the entry of some progenitors into the developmental pathway, by
repressing the expression of critical genes of the regulatory net-
work driving differentiation, then its inactivation would be ex-
pected to cause premature commitment of these progenitors.
However, deleting Rest in early progenitors that express Pdx1 did
not result in any increase of endocrine progenitors and endocrine
cells. This is surprising as REST was shown to bind the Neurog3
regulatory sequences, and our gain-of-function experiments in-
deed suggest that Neurog3 is repressed by REST. It is probable that
Neurog3 expression and endocrine pathway entry are gated not
only by REST but also by other REST-independent repression me-
chanisms. Other pathways gating endocrine differentiation such as
the Notch pathway and its effector HES1 may restrain endocrine
differentiation in parallel (Jensen et al., 2000). Different repressive
complexes have been involved in development, especially those
driving chromatin modiﬁcations (Laugesen and Helin, 2014). It
was recently shown that REST and Polycomb repressions act in
parallel in neuronal (McGann et al., 2014) as well as in pancreatic
beta-cells differentiations (van Arensbergen et al., 2010). Indeed, in
pancreatic progenitors, PcG marks a wide number of disallowed
genes for beta cells, including regulators of alternate develop-
mental fate, while REST binds in ES cells to genes that later se-
lectively lack PcG repression in beta cells. Furthermore, the Rest
gene acquires a PcG-mediated H3K27me3 repressive mark after
the pancreatic precursor stage, that coincides with the activation
of a core beta-cell derepression program (van Arensbergen et al.,
2010). CoREST, ﬁrst identiﬁed as a component of the REST complex
(Andres et al., 1999), also appears to act independently of REST, by
binding to a differential set of genes (Abrajano et al., 2009), and toements. (A) qPCR analysis on E12.5 pancreatic buds from controls (REST Fl/Fl; n¼5)
pression of Rest. We observed a relieved expression for several REST target genes,
ean7SD. *po0.05; **po0.01; ***po0.001. (B) qPCR analysis on E12.5 pancreatic
evels of expression of Celsr3, but not of the other family member Celsr1 or Vangl2.
tering analysis of gene expression from single cells isolated from E12.5 pancreatic
genotype, for which qPCR analysis yielded clustering of different cell populations
alyzed, according to global Z score. REST Fl/Fl-Cre_Cluster 2 cells differ from control
ows clustering of the REST Fl/Fl-Cre_Cluster 1 cells with control cells, while REST Fl/
ked according to the order of PCA gene score. REST Fl/Fl-Cre_Cluster 2 cells express
s REST target genes (including Chgb, Mapk8ip1, Hnf4a, Chga, Mafb, Celsr3, Onecut2,
single cells used in panels C and D. While control cells express various levels of Rest,
s were determined using non-parametric two-way Mann–Whitney test. **po0.01;
D. Martin et al. / Developmental Biology 405 (2015) 316–327326be sufﬁcient in itself to control cortical neuron differentiation
(Ballas et al., 2005; Fuentes et al., 2012; Volvert et al., 2014). It may
also control endocrine differentiation with or without REST. Al-
though Rest depletion is not sufﬁcient to initiate endocrine cell
formation, an important subset of the endocrine differentiation
program is activated and is therefore not under the control of
multiple repressors. Indeed, several endocrine markers are up-
regulated in the KO. The control over a subprogram is in agree-
ment with observations in Rest-deﬁcient mice (Aoki et al., 2012) or
zebraﬁsh (Kok et al., 2012) in the context of neuron speciﬁcation.
The targets appear to affect a variety of functions rather than a
speciﬁc class. Indeed, genes as diverse as those encoding tran-
scription factors (Onecut1, Onecut2, Hnf4a, Myt1, Arx, Neurod1,
Mafb), proteins acting in insulin maturation (Pcsk1, Pcsk2), insulin
secretion (Chga, Chgb, Syt4), cell to cell communication (Gjd2,
Mfng), anti-apoptotic activity (Ptprn, Cdk5r2) or differentiation
functions (Celsr3) were affected upon Rest deletion. Some genes
with a RE-1 motif were detected as REST-dependent only in the
more sensitive single-cell PCR assay (Hnf4a, Onecut1, Arx, Chga,
Mnfg, Neurod1) and some were not de-repressed as for example
Neurog3 and Hes1. This was independent of the level of con-
servation of their RE-1 motif (Supplemental Fig. 3). The expression
of unaffected genes may be gated by multiple repressors. Of in-
terest, only a subset of the target genes of REST in the pancreas is
also under REST repression in the nervous system. This is for ex-
ample the case of the gene under strongest repression in pancreas,
Celsr3 (Jia et al., 2014) and Syt4, although this has been shown in
vitro (Ballas et al., 2005), but not conﬁrmed in vivo (Aoki et al.,
2012). In contrast, the fact that other targets regulated in the
pancreas are not in the nervous system, as observed for Gjd2 (Hohl
and Thiel, 2005) and for Pcsk1 (McClelland et al., 2014), suggests
that transcriptional repression by REST may function in a cell type-
speciﬁc manner. Indeed, the fact that REST represses distinct sets
of genes in different cell types has already been noticed and ac-
counted for by the level of REST protein and the sequence varia-
tions in the RE-1 motif (Bruce et al., 2009; Johnson et al., 2008).
The single-cell PCR also revealed that inactivated cells tend to
increase both Glucagon, an endocrine marker, and progenitor
genes. The activation of progenitor genes may be due to non-cell
autonomous outcomes of partial or non-synchronous REST in-
activation inducing feed-back responses. In addition, the induction
of Glucagon and to some extent Insulin and other endocrine genes
devoid of known RE-1 motifs may be secondary. Primary REST
targets inducing this effect remain unknown and may not be de-
tected as robustly as Glucagon, as single cell PCR is noisy for genes
expressed at low levels, which is frequent for transcription factors.
Interestingly the induction of Glucagon did not result in an in-
crease of cells expressing Glucagon protein, which may result from
translational control or too low a level of Glucagon transcript
induction.
Taken together our study shows for the ﬁrst time that en-
dogenous REST plays a repressive role during pancreas develop-
ment and that multiple repression programs function in parallel,
but with likely overlaps, to gate endocrine differentiation. This
positions REST as a potential repressor of maturation limiting the
production of fully functional beta cells from ES cells in vitro. It will
be important to monitor its repression during differentiation
protocols producing beta cells, all the more that during the in vitro
production the expression levels of some of REST target genes do
not reach the expression levels found in beta cells in vivo (Pagliuca
et al., 2014; Rezania et al., 2014).
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